The General Assembly’s Regulations Review Committee has agreed that chronic neuropathic pain associated with degenerative spinal disorders is eligible for treatment with the drug.
With this change, there are now 31 conditions that have been approved for adults and eight for patients under 18 that can be treated with medical marijuana.
Related Content: After long wait, 1st legal pot shops on East Coast to open
The committee also has agreed to update state regulations to accommodate the federal Food and Drug Administration’s recent approval of a cannabis-based medication. The oral solution, known as Epidiolex, is used for some rare, severe seizure disorders.
There are currently 29,543 patients in Connecticut’s medical marijuana program and 1,000 certifying physicians.